Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $39.98 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Barclays sees global expansion intact, warns against market complacency
• Yiren Digital Ltd. (YRD) Reports Q1 Loss of RMB5.64
• Flash Sports & Media plans Zimbabwe T20 cricket league for 2026